Inotiv (NOTV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Inotiv (NOTV)
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Key Insights
Critical company metrics and information
Share Price
$4.56Market Cap
$118.68 MillionTotal Outstanding Shares
26.02 Million SharesTotal Employees
2,075Dividend
No dividendIPO Date
November 25, 1997SIC Description
Services-commercial Physical & Biological ResearchHomepage
https://www.inotivco.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $-13.96 Million |
Net Cash Flow From Investing Activities, Continuing | $-16.83 Million |
Net Cash Flow From Financing Activities | $9.68 Million |
Net Cash Flow From Financing Activities, Continuing | $9.68 Million |
Net Cash Flow From Operating Activities, Continuing | $-6.80 Million |
Net Cash Flow | $-14.06 Million |
Net Cash Flow From Investing Activities | $-16.83 Million |
Exchange Gains/Losses | $-98,000.00 |
Net Cash Flow From Operating Activities | $-6.80 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Income/Loss From Continuing Operations Before Tax | $-130.76 Million |
Income Tax Expense/Benefit | $-21.88 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $-440,000.00 |
Net Income/Loss Available To Common Stockholders, Basic | $-108.44 Million |
Other Operating Expenses | $520.03 Million |
Depreciation and Amortization | $57.12 Million |
Net Income/Loss Attributable To Parent | $-108.44 Million |
Costs And Expenses | $621.50 Million |
Basic Earnings Per Share | $-4.19 |
Income/Loss From Continuing Operations After Tax | $-108.89 Million |
Diluted Earnings Per Share | $-4.19 |
Benefits Costs and Expenses | $621.50 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Operating Expenses | $577.14 Million |
Operating Income/Loss | $-86.41 Million |
Diluted Average Shares | $25.90 Million |
Revenues | $490.74 Million |
Basic Average Shares | $25.90 Million |
Net Income/Loss | $-108.89 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Liabilities | $610.86 Million |
Noncurrent Assets | $617.95 Million |
Inventory | $18.17 Million |
Other Current Liabilities | $85.52 Million |
Accounts Payable | $33.53 Million |
Current Assets | $163.41 Million |
Long-term Debt | $393.34 Million |
Equity | $170.50 Million |
Other Non-current Liabilities | $98.48 Million |
Liabilities And Equity | $781.36 Million |
Equity Attributable To Parent | $170.50 Million |
Fixed Assets | $188.33 Million |
Assets | $781.36 Million |
Noncurrent Liabilities | $491.81 Million |
Other Non-current Assets | $429.62 Million |
Current Liabilities | $119.04 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Other Current Assets | $145.24 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.